Flonase Users Seek Sanctions For Foes Of $35M Antitrust Deal

Law360, New York (May 24, 2013, 2:42 PM EDT) -- Flonase purchasers urged a Pennsylvania federal court Thursday to sanction objectors to a $35 million class action settlement of allegations that GlaxoSmithKline PLC improperly delayed market entry of a generic nasal spray, saying the two objectors and their attorneys ignored a court order.

A group of indirect purchasers of Flonase filed a motion for sanctions against James Payton and Jill Jan — putative class members who lodged objections to a proposed settlement of antitrust claims brought against GSK — as well as attorney Darrell Palmer and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.